Lehigh Names New Trustees

The new trustees are:

Faith R. Glazier ’87 ’19P

Faith Glazier is a Principal at Deloitte. She has over 30 years of experience providing Strategy, Operations and Technology consulting services to leading life sciences organizations, including pharmaceutical, biotech, medical device and diagnostic companies. She has served some of the firm’s most important clients as the Lead Client Service Partner. In that role Faith has been responsible for bringing all of Deloitte’s expertise to the client and providing oversight on all projects Deloitte delivers.

Faith currently serves on the Deloitte Consulting Board of Directors as well as the Deloitte Political Action Committee Board of Directors. Previously, she served as the Global Leader for Deloitte’s Generics Pharmaceutical Practice, and was responsible for the thought leadership, market eminence and project delivery for clients in this segment of the market.

Faith is active in recruiting and mentoring talent. She serves as the Advisory Partner for Harvard University and leads Deloitte’s efforts there, as well as the School Champion for recruiting for Consulting at Lehigh University.

In addition to 32 years at Deloitte, Faith was a founding partner of Archstone Consulting and spent two years as a Litigation Consultant for Peterson & Co.

Faith is a former board member for the Volunteer Consulting Group, and a former member of the Lehigh University College of Business’ Dean’s Advisory Council.

Faith graduated from Lehigh University with a B.S. in Business and Economics. She has an M.B.A. from the Harvard University Graduate School of Business Administration.

Christopher D. Hite ’89 ’20P ’24P

Christopher Hite is an Executive Vice President and Vice Chairman of Royalty Pharma and has over 25 years of experience advising biopharmaceutical companies on mergers and acquisitions and capital formation. Prior to joining Royalty Pharma in 2020, Mr. Hite was an investment banker at Citi where he was the Global Head of Healthcare for nearly 12 years and most recently a Vice Chairman of Banking, Capital Markets and Advisory (“BCMA”) and sat on the Executive Committee of BCMA. Prior to joining Citi, Mr. Hite was the Global Head of Healthcare Investment Banking at Lehman Brothers.  Mr. Hite serves on the Board of Advisors of Faster Cures, a center of the Milken Institute, and served on the Board of Directors and as Chairman of the Audit Committee of Acceleron Pharma Inc. (Nasdaq: XLRN) until its acquisition by Merck in November 2021 for $11.5 billion. Mr. Hite has a BS from Lehigh University and a JD and MBA from the University of Pittsburgh.

Stephen S. Tang ’85G ’88G ’22P

Steve most recently served as President & CEO of OraSure Technologies Inc. His other executive positions include a ten-year tenure with University City Science Center as president and CEO during which time they strategically transformed into an innovation powerhouse, as well as growing large profitable businesses for Olympus America and two leading global management consulting firms.

He has served on leading nonprofit boards such as the U.S. Department of Commerce’s National Advisory Council on Innovation and Entrepreneurship which he co-chaired. He’s also been the first person of color elected chairman of Team Pennsylvania Foundation and the Committee of Seventy.

Mary Beth Tully ’84 ’21P ’21P

Mary Beth Tully graduated from Lehigh University in 1984 and holds a MPA in Health Policy and Management from New York University’s Robert F. Wagner Graduate School of Public Service. She has worked professionally in both the public and non-profit sectors, and in recent years has devoted her time to various volunteer causes.

She was elected to the New York Junior League (NYJL) in 1992 and served as its President from 2002-2004. She led Building Opportunities: the NYJL Second Century Campaign, the NYJL’s largest capital and endowment campaign and the renovation of the NYJL’s landmarked New York City Headquarters. Ms. Tully was recently recognized as a 2021 NYJL Outstanding Sustainer.

Ms. Tully is a member of the United Hospital Fund’s Board of Directors and serves as a member of the Board’s Development and Program committees. Previously, she was a long-term member of the Board of Palladia, Inc., a New York City nonprofit, multiservice substance abuse and homeless service agency prior to its merger with Services for the Underserved. In addition, Ms. Tully recently completed her term as President of the Lehigh University Alumni Association Board of Directors.

For more than ten years, Ms. Tully worked with New York City’s medically underserved communities as a hospital administrator, and health care policy and financial analyst with the New York City Health & Hospitals Corporation (HHC), the nation’s largest public hospital system. While at HHC, Ms. Tully was selected as a Health Policy Fellow of the National Association of Public Hospitals & Health Systems. Ms. Tully moved from public service to the nonprofit sector and was appointed Chapter Director for the Greater New York chapter of the American Liver Foundation.

In her local community, Ms. Tully is an elected director of Garden City’s Central Property Owners’ Association and serves as its treasurer. From 2011 - 2019, she served on the NYU Winthrop-University Hospital (NYU Long Island) Board of Directors as a member of the Board’s Executive Compensation and Quality Committees and co-chaired the hospital's $25.0 million capital campaign steering committee for a new research and clinical building. Since 2010, Ms. Tully has served as an alumnae volunteer chapter advisor for Alpha Phi International Fraternity’s collegiate chapter at Hofstra University. In 2012 she was named to the Alpha Phi Foundation Board of Directors based in Chicago, IL and served as Board Chair from 2018 – 2022. Under her leadership, the Alpha Phi Foundation concluded its $43 million Leading with Heart campaign, setting a new standard of philanthropic support for fraternal women’s organizations.

Visit the Board of Trustees website.